2024 : 11 : 22
Malek Soleimani mehranjani

Malek Soleimani mehranjani

Academic rank: Professor
ORCID: https://orcid.org/0000-0003-4822-2617
Education: PhD.
ScopusId: 6505623754
HIndex:
Faculty: Science
Address: Arak University
Phone:

Research

Title
Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI
Type
JournalPaper
Keywords
Polycystic Ovary Syndrome, Metformin, N-Acetyl Cysteine, Insulin Resistance, Oxidative Stress
Year
2014
Journal International Journal of Fertility & Sterility
DOI
Researchers Ebrahim Cheraghi ، Malek Soleimani mehranjani ، Seyed Mohammadali Shariatzadeh ، mohammad hossein nasr esfahani ، zahra ebrahimi

Abstract

ing insulin resistance and N-acetyl cysteine (NAC) in inhibiting oxidative stress which are involved in the pathogenesis of polycystic ovarian syndrome (PCOS). We aimed to compare the effects of MTF and NAC combination on serum metabolite and hormonal levels during the course of ovulation induction in PCOS individual candidates of intracytoplasmic sperm injection (ICSI). In this prospective randomized clinical trial, placebo controlled pilot study, 80 patients of polycystic ovarian syndrome at the age of 25-35 (600 mg three times daily), ii. MTF=treated with metformin (500 mg three times daily), iii. MTF+NAC=treated with N-acetyl cysteine plus metformin (the offered doses) and iv. placebo (PLA). A total number of 20 patients (6 from MTF group, 4 from NAC group, 6 from MTF+NAC group and 4 from PLA group) were dropped of the study. The drugs were administrated from day 3 of menses of previous cycle until ovum pick-up. Serum levels of luteinizing hormone (LH), total testosterone, cholesterol and triglyceride, insulin and leptin significantly reduced in the MTF and NAC groups compared to the placebo (p<0.01). But levels of LH, total testosterone, cholesterol and triglyceride had no significant reduction in the MTF+NAC groups com leptin reduced significantly after treatment in the MTF+NAC group compared to the placebo (p<0.05). Considering the adverse effect of combination therapy, we proposed the con